Direct PCR Buffer for Crude Sample Amplification

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for DNA analysis in forensic casework require time-consuming and costly DNA isolation and purification steps before PCR amplification, especially when dealing with crude samples like blood and buccal swabs, which often contain inhibitors that hinder polymerase activity.

Innovation Solution

A direct PCR method using a buffer comprising 3%-8% glycerol, 0.2%-0.9% non-ionic surfactants, 1000-3000 ug/ml BSA, and specific PCR primer pairs, which allows for direct amplification of nucleic acids from crude samples without prior purification, using NaOH incubation and a buffer with 10-50 mM Tris-HCl, 30-80 mM KCl, 1.4-2.4 mM MgCl2, 0.01%-0.04% Sodium azide, and 0.10-0.35 U/ul of DNA polymerase.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If DNA isolation and purification methods are used before PCR amplification, then the activity of polymerases is protected from inhibition, but time and expense are added to the preparation of samples

Engineering Contradiction:
Improvepolymerase activityVSAvoidsample preparation time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent extracts and removes inhibitors from crude samples through a purification step that eliminates substances interfering with polymerase activity, while specifically excluding polysorbate from the purification process. This allows direct PCR amplification without requiring traditional DNA isolation procedures, thereby reducing sample preparation time while maintaining polymerase functionality.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent introduces an intermediary substance (polysorbate-free buffer system) that mediates between the crude sample containing inhibitors and the polymerase enzyme. This intermediary buffer system neutralizes or sequesters inhibitors, protecting polymerase activity without requiring time-consuming DNA purification steps.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If DNA isolation and purification methods are used before PCR amplification, then the activity of polymerases is protected from inhibition, but expense is added to the preparation of samples

Engineering Contradiction:
Improvepolymerase activityVSAvoidsample preparation cost
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The patent extracts and removes inhibitors from crude samples through a purification step that eliminates substances interfering with polymerase activity, while specifically excluding polysorbate from the purification process. This allows direct PCR amplification without requiring traditional DNA isolation procedures, thereby reducing sample preparation time while maintaining polymerase functionality.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent employs a cost-effective buffer system without polysorbate that provides sufficient protection for polymerase activity at low cost. This disposable-like approach uses simple, inexpensive reagents that can be directly applied to crude samples, eliminating the need for expensive commercial DNA isolation kits while maintaining adequate polymerase protection.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

3Productivity

If crude samples are used directly for PCR amplification, then sample preparation time and costs are reduced, but inhibitors in the samples can hinder polymerase activity

Engineering Contradiction:
Improvesample preparation efficiencyVSAvoidpolymerase activity
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent converts the harmful effect of inhibitors in crude samples into a beneficial outcome by using a specialized buffer system that selectively neutralizes inhibitors while preserving DNA integrity. The polysorbate-free formulation specifically targets and eliminates inhibitory substances, allowing direct PCR amplification of crude samples without compromising polymerase activity.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Solution Approach 2:

The patent changes the chemical parameters of the buffer system by excluding polysorbate and adjusting buffer composition to optimize inhibitor removal. This parameter change allows the buffer to selectively bind or neutralize inhibitors while maintaining conditions favorable for polymerase activity, enabling direct amplification from crude samples.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method significantly reduces sample preparation time and costs by eliminating the need for DNA purification, enhancing the success rate of obtaining full STR profiles from crude samples, and is compatible with existing automation instruments, while minimizing the risk of cross-contamination and human errors.

Implementation Method 1

optionally incubating the crude sample with NaOH at 5 mM to 25 mM

Methodology Applied
Scientific EffectProtein denaturation:

Implementation Method 2

the direct buffer comprises at least 3%-8% glycerol, 0.2%-0.9% non-ionic surfactants

Methodology Applied
Scientific EffectSurfactant protection: Surfactant

Implementation Method 3

1000-3000 ug/ml BSA

Methodology Applied
Scientific EffectProtein binding: Absorption (physical)

Implementation Method 4

performing a PCR on the deoxyribonucleic acid

Methodology Applied
Scientific EffectDNA replication: Enzyme

Data Source

PatentUS9518302B2Method for direct amplification from crude nucleic acid samples
Publication Date: 2016.12.13 LIFE TECHNOLOGIES CORP
  • US9518302B2 patent drawing
  • US9518302B2 patent drawing
  • US9518302B2 patent drawing

AI summary

The present teachings relate to improved methods, kits, and reaction mixtures for amplifying nucleic acids. In some embodiments a novel direct buffer formulation is provided which allows for the direct amplification of the nucleic acids in a crude sample with minimal sample purification.